Why the study?
Does loratadine inhibit potassium currents in human atrial myocytes?
Does loratadine inhibit potassium currents in human atrial myocytes?
Loratadine rate-dependently inhibits the transient outward potassium current in human atrial myocytes, providing a potential mechanism for associated supraventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
May increase supraventricular arrhythmia risk via Ito inhibition; leaves open clinical relevance pending human studies.
The antihistamine loratadine is widely prescribed for the treatment of symptoms associated with allergies. Although generally believed to be free of adverse cardiac effects, there are a number of recent reports suggesting that loratadine use may be associated with arrhythmias, in particular atrial arrhythmias. Nothing is known regarding the potassium channel blocking properties of loratadine in human cardiac cells. Using the whole-cell patch clamp technique, the effects of loratadine on the transient outward K current (Ito), sustained current (Isus), and current measured at -100 mV (IK1 and Ins), the major inward and outward potassium currents present in human atrial myocytes, were examined in order to provide a possible molecular mechanism for the observed atrial arrhythmias reported with loratadine use. Loratadine rate-dependently inhibited Ito at therapeutic concentrations with 10 nM loratadine reducing Ito amplitude at a pacing rate of 2 Hz by 34.9+/-6.0%. In contrast, loratadine had no effect on either Isus or current measured at -100 mV. These results may provide a possible mechanism for the incidences of supraventricular arrhythmias reported with the use of loratadine.
No takes yet. Share an insight, caveat, or question.
William Crumb (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: